Home > News > Bring on the nanobots, and we will live long and prosper
November 22nd, 2007
Bring on the nanobots, and we will live long and prosper
Extending human life expectancy is not a new story. When our genes evolved thousands of years ago, it was not in the interests of the species for people to live past child-rearing as resources such as food were in very short supply. So human life expectancy was in the 20s a thousand years ago. It was only 37 in 1800. It is now pushing 80, and we have been adding about three months each year for the past several decades.
Within a couple of decades, we will have "nanobots" in our blood stream, basically small robots the size of blood cells, that will keep us healthy at the cellular and molecular level. There are already dozens of successful experiments with a first generation of such devices in animals. One scientist cured type-I diabetes in rats with a blood cell-sized device, and scientists at MIT have microscopic devices that can scout out cancer cells in the bloodstream and destroy them. These devices will be a billion times more powerful than they are today in 25 years, and will continue the accelerating path to radical life extension.
Study finds long-term survival of human neural stem cells transplanted into primate brain April 23rd, 2014
High-Performance, Low-Cost Ultracapacitors Built with Graphene and Carbon Nanotubes: Future devices based on technology could bridge gap between batteries and conventional capacitors in portable electronics and hybrid electric vehicles April 23rd, 2014
Guo Lab Shows Potential of RNA as Heat-resistant Polymer Material for Nanoarchitectures April 23rd, 2014
Berkeley Lab Researchers Demonstrate First Size-based Chromatography Technique for the Study of Living Cells April 22nd, 2014
Conceptual Nanomedical Lipofuscin Removal Strategy April 29th, 2013
utsandiego.com November 22nd, 2012
Nanoparticles against aging October 3rd, 2012
Frost & Sullivan Hosts Webinar: Can We Live Forever? Gauging the Future Trajectory of Medical Technology Development March 24th, 2011